哈林顿器械固定与融合治疗青少年特发性脊柱侧凸后长期健康相关生活质量:至少40年随访
该研究评估1961至1977年接受哈林顿器械后路脊柱内固定与融合(PSIF)的青少年特发性脊柱侧凸(AIS)患者长期健康相关生活质量及再手术需求,平均随访45.4年。远端固定椎(LIV)为L4或更远端的患者再手术率高于LIV为L3或更近端的患者,再手术者生活质量较低,但LIV L4或远端与L3或近端患者的生活质量无显著差异,整体生活质量与年龄匹配的美国常模相当。
要点
- LIV L4或远端患者再手术率为36.4%,LIV L3或近端为12.8%,比值比为3.98。
- 未再手术者中,LIV L4或远端与L3或近端患者的ODI和SRS-7评分差异无统计学意义。
- 接受再手术的患者健康相关生活质量低于未再手术者。
核心结论
- 平均随访45年时,LIV L4或远端的AIS患者再手术率高于LIV L3或近端者,再手术者生活质量较低,但不同LIV组间生活质量无差异,整体生活质量与年龄匹配一般人群相当。
研究设计与样本
- 研究为治疗性IV级证据,检索并联系314例1961至1977年由L.A. Goldstein医生行PSIF的AIS患者,评估再手术、ODI、SRS-7、EQ-5D和PROMIS-29。
主要发现
- 134例(42.7%)被识别,24例(7.6%)死亡,81例(25.8%)同意参与,29例(9.2%)拒绝;平均随访45.4年(范围40至56年)。
- 81例完成调查,77例完成SRS-7,77例完成ODI,76例完成PROMIS-29和EQ-5D。
- LIV L3或近端患者12.8%再手术,LIV L4或远端患者36.4%再手术,比值比为3.98。
- 再手术者与未再手术者ODI分级:最小残疾分别为42%和73%,中度残疾分别为53%和23%,严重残疾分别为5%和2%。
- 未再手术者中,LIV L3或近端ODI平均14.12分、SRS-7平均23.3分,LIV L4或远端ODI平均17.9分、SRS-7平均22.7分,差异无统计学意义;PROMIS-29和EQ-5D平均分与正常美国年龄匹配均值无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite its importance for clinical decisions, the long-term consequences of posterior spinal instrumentation and fusion (PSIF) for adolescent idiopathic scoliosis (AIS), particularly in the lower lumbar spine, remain unclear. This study evaluates the long-term health-related quality of life and the need for a further surgical procedure in patients treated with Harrington instrumentation from 1961 to 1977 according to the lowest instrumented vertebra (LIV) and in comparison with age-matched norms. METHODS: A search was performed to identify and contact the 314 identified patients with AIS treated with PSIF by Dr. L.A. Goldstein. The assessment included identified subsequent spine surgery, the Oswestry Disability Index (ODI), Scoliosis Research Society-7 (SRS-7), EuroQol-5 Dimensions (EQ-5D), and Patient-Reported Outcomes Measurement Information System-29 (PROMIS-29). The health-related quality of life was compared with U.S. norms and, within the cohort, was compared by patient factors, LIV, and subsequent spine surgery. RESULTS: In this study, 134 patients (42.7%) were identified; 24 (7.6%) had died, 81 (25.8%) consented to participate in the study, and 29 (9.2%) declined participation. The mean follow-up was 45.4 years (range, 40 to 56 years). There were 81 patients who completed the surveys, 77 patients who completed the SRS-7, 77 patients who completed the ODI, and 76 patients who completed the PROMIS-29 and EQ-5D. There were 12.8% of patients with LIV L3 or proximal and 36.4% with LIV L4 or distal who had an additional surgical procedure (odds ratio, 3.98). Comparing the ODI of patients who had undergone an additional surgical procedure with those who had not showed 42% and 73% minimal disability, 53% and 23% moderate disability, and 5% and 2% severe disability. Of the patients who had not undergone an additional surgical procedure, those with LIV L3 or proximal had mean scores of 14.12 points for the ODI and 23.3 points for the SRS-7 and those with LIV L4 or distal had mean scores of 17.9 points for the ODI and 22.7 points for the SRS-7; these differences were not significant. The mean PROMIS-29 and EQ-5D scores were not different from normal U.S. age-based means. CONCLUSIONS: Patients with AIS treated with PSIF at a mean 45-year follow-up and LIV L4 or distal had a higher rate of undergoing an additional surgical procedure than those with LIV L3 or proximal. Patients undergoing an additional surgical procedure had lower health-related quality of life than those who did not. Despite this, there was no difference in health-related quality of life for patients with LIV L4 or distal compared with patients with LIV L3 or proximal. This cohort of patients with AIS treated with PSIF demonstrates normal self-reported health-related quality of life compared with the age-matched general population. These long-term outcomes of PSIF for AIS are encouraging. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Lander ST, Thirukumaran C, Saleh A, et al. Long-Term Health-Related Quality of Life After Harrington Instrumentation and Fusion for Adolescent Idiopathic Scoliosis: A Minimum 40-Year Follow-up. J Bone Joint Surg Am. 2022. PMID: 35648066. doi:10.2106/JBJS.21.00763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。